Reaction

Ureteric Cancer reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 400 reports · 3 co-occurring drugs

As of the last recalculation, Ureteric Cancer appears in 400 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is PIOGLITAZONE (PRR 59.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Pioglitazone4459.459.4
Methoxy Polyethylene Glycol-Epoetin Beta419.019.0
Ranitidine Hydrochloride1110.810.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.